PODD · 10-Q · 2026Q3 · Full report

Capital Expenditures Program

INSULET CORP · 2026-11-04 · Importance 38 · Surprise 24 · In source text

Insulet spent $113.9 million on capital expenditures during the nine months ended September 30, 2026, including purchases of machinery, equipment, and tooling for existing manufacturing facilities and investments in its Costa Rica manufacturing plant. The company said it expects 2026 capital expenditures to increase compared with 2025 to support continued global manufacturing expansion plans. No facility utilization rates or output-capacity figures are provided in this discussion.

Key facts

• Capital expenditures were $113.9 million for the nine months ended September 30, 2026, compared with $56.5 million in 2025; the $57.5 million increase primarily related to machinery, equipment and tooling for existing facilities and investments in the Costa Rica manufacturing plant. source
• Insulet’s capital expenditures were $113.9 million for the nine months ended September 30, 2026, compared with $56.5 million for the same period in 2025. source
• In April 2026, Insulet guaranteed potential future payments related to the seller’s loan used to finance construction of its Costa Rica manufacturing plant. source
• Insulet expects 2026 capital expenditures to increase compared with 2025 to support continued global manufacturing expansion, funded using existing cash and financing. source
• Developed-software investments were $13.1 million for the nine months ended September 30, 2026, primarily related to cloud-based capability projects. source
• Insulet is investing in a new manufacturing plant in Costa Rica to support continued growth and future demand. source
• Insulet entered an agreement in 2025 for the construction and future purchase of a manufacturing plant in Costa Rica; the arrangement includes a finance lease for the land. source

Impact estimates